Literature DB >> 3622502

In vitro activity of four new quinolones in Mueller-Hinton broth and peritoneal dialysis fluid.

C Weissauer-Condon, I Engels, F D Daschner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3622502     DOI： 10.1007/bf02017630

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  5 in total

1.  Peritonitis in continuous ambulatory peritoneal dialysis.

Authors:  R Gokal
Journal:  J Antimicrob Chemother       Date:  1982-06       Impact factor: 5.790

2.  Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluids.

Authors:  H A Verbrugh; W F Keane; W E Conroy; P K Peterson
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

3.  In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid.

Authors:  I Shalit; D F Welch; V H San Joaquin; M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

4.  Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620.

Authors:  L Hirschhorn; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

5.  Pharmacokinetics of single-dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysis.

Authors:  I Shalit; R B Greenwood; M I Marks; J A Pederson; D L Frederick
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191
  5 in total
  5 in total

1.  Efficacy of ciprofloxacin in treatment of CAPD peritonitis.

Authors:  A C Scott; L W Fleming; W K Stewart
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

2.  Influence of carbon dioxide on growth and antibiotic susceptibility of coagulase-negative staphylococci cultured in human peritoneal dialysate.

Authors:  M H Wilcox; D G Smith; J A Evans; S P Denyer; R G Finch; P Williams
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

Review 3.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

4.  Susceptibility testing of bacteria recovered from patients with peritonitis complicating continuous ambulatory peritoneal dialysis.

Authors:  H Ludlam; L Johnston; P Hopkins
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

5.  Improving the N-terminal diversity of sansanmycin through mutasynthesis.

Authors:  Yuanyuan Shi; Zhibo Jiang; Xuan Lei; Ningning Zhang; Qiang Cai; Qinglian Li; Lifei Wang; Shuyi Si; Yunying Xie; Bin Hong
Journal:  Microb Cell Fact       Date:  2016-05-06       Impact factor: 5.328
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.